Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?

Lancet Oncol. 2016 Feb;17(2):e43-e44. doi: 10.1016/S1470-2045(16)00024-3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Lung Neoplasms / therapy*
  • Male
  • Mesothelioma / therapy*
  • Neoadjuvant Therapy*
  • Pleural Neoplasms / therapy*
  • Pneumonectomy*
  • Radiotherapy Dosage*